Recommendation to Use Wearable-Based mHealth in Closed-Loop Management of Acute Cardiovascular Disease Patients During the COVID-19 Pandemic

Ji, Nan; Xiang, Ting; Bonato, Paolo; Lovell, Nigel H.; Ooi, Sze-Yuan; Clifton, David A.; Akay, Metin; Ding, Xiaorong; Yan, Bryan P.; Mok, Vincent Chung Tong; Fotiadis, Dimitrios I.; Zhang, Yuan-Ting

doi:10.1109/jbhi.2021.3059883

Cited by 29 publications

(6 citation statements)

References 24 publications

(25 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus, the proposed device has the potential to help in finding dysfunction in the autonomic nervous system. The proposed smart wearable device can identify and measure different nasal parameters in breathing disorders like sleep apnea [77], hyperventilation (breathing very fast), Kussmaul breathing (deep and labored breathing), identifying shortness of breath in the COVID-19 [78], bradypnea (abnormally slow breathing), and sinus arrhythmia. The present commercial instruments are still an expensive option in measuring the nasal cycle parameters continuously over time and are also not comfortable in continuously monitoring the nasal breathing parameter.…”

Section: Discussionmentioning

confidence: 99%

Temperature Profile of Nasal Breathing for Respiration Monitoring in Ambulatory Settings

2022

View full text Add to dashboard Cite

The nasal breathing parameters have shown promising applications in hyperventilation, Kussmaul breathing, sleep apnea, shortness of breath in COVID-19, bradypnea, sinus arrhythmia, and breathing pranayama. However, a wearable setup, which is affordable, aesthetic, and accurate in real-time during various physical activities, is not available currently. The present work develops a novel, low-cost and wearable instrumented Nasal Temperature Sensing (NTS) device for measuring various breathing parameters. The proposed device was tested during controlled breathing exercises in seated position at three ambient temperature settings (18°C, 28°C, and 38°C). The device was further tested for standing and walking at various speeds including slow (1.5 Km/hr), medium (3.5 Km/hr), and fast (5.5 Km/hr). The NTS device is compared against a commercially available respiration belt (gold standard). The mean absolute error (averaged across subjects and ambient temperature settings) was 0.09±0.05 breaths per minute (bpm), 0.17±0.10 bpm, and 0.13±0.13 bpm for controlled breathing at 6 bpm, 12 bpm, and 18 bpm, respectively. The Root-mean-square error between the NTS device and respiration belt across the subjects at the normal standing-position was 1.13±0.39 bpm. The results suggest that the proposed NTS device is accurate for real-time applications with the potential advantage of being robust enough to motion artifacts.

show abstract

Section: Discussionmentioning

confidence: 99%

Temperature Profile of Nasal Breathing for Respiration Monitoring in Ambulatory Settings

2022

View full text Add to dashboard Cite

show abstract

“…The COVID-19 pandemic has accelerated the development and deployment of digital technologies for remote patient monitoring, which can include the use of portable/wearable devices, mobile and cloud applications, and IoT framework [10], [14], [15], [16]. Zhang and Ling proposed a telehealth monitoring system to monitor multiple physiological parameters including respiration rate (RR), heart rate (HR), body temperature, blood oxygen saturation (SpO2), blood pressure, and electrocardiogram (ECG) [17].…”

Section: Related Workmentioning

confidence: 99%

“…The number of people experiencing long COVID-19 is unknown. According to a survey from the U.K. Government's [10] Office for National Statistics in November 2020, it was estimated that 1 in 5 people had symptoms for more than 5 weeks and 1 in 10 people had symptoms beyond 12 weeks [8]. Long COVID-19 can affect multiple systems in the body including (not limited to) the respiratory and cardiovascular systems [9].…”

Section: Introductionmentioning

confidence: 99%

Respinos: A Portable Device for Remote Vital Signs Monitoring of COVID-19 Patients

Adiono

Ahmadi

Saraswati³

et al. 2022

IEEE Trans. Biomed. Circuits Syst.

View full text Add to dashboard Cite

The rapidly increasing number of COVID-19 patients has posed a massive burden on many healthcare systems worldwide. Moreover, the limited availability of diagnostic and treatment equipment makes it difficult to treat patients in the hospital. To reduce the burden and maintain the quality of care, asymptomatic patients or patients with mild symptoms are advised to self-isolate at home. However, self-isolated patients need to be continuously monitored as their health can turn into critical condition within a short time. Therefore, a portable device that can remotely monitor the condition and progression of the health of these patients is urgently needed. Here we present a portable device, called Respinos, that can monitor multiparameter vital signs including respiratory rate, heart rate, body temperature, and SpO2. It can also operate as a spirometer that measures forced vital capacity (FVC), forced expiratory volume (FEV), FEV in the first second (FEV1), and peak expiratory flow Rate (PEFR) parameters which are useful for detecting pulmonary diseases. The spirometer is designed in the form of a tube that can be ergonomically inflated by the patient, and is equipped with an accurate and disposable turbine based air flow sensor to evaluate the patient's respiratory condition. Respinos

show abstract

“…Integrating digital health information into the health-care system is also a possible solution for improving the quality of care, especially during the COVID-19 pandemic. 65 As STEMI is a time-sensitive emergency, advances in real-time wearable technologies have vast potential in diagnosing and managing this condition.…”

Section: Wearable Technologies and Artificial Intelligence In Stemi Carementioning

confidence: 99%

Quality care in ST-segment elevation myocardial infarction

Liu

Hung

Chiang

et al. 2022

Journal of the Chinese Medical Association

View full text Add to dashboard Cite

Over the past decades, the treatment of ST-segment elevation myocardial infarction (STEMI) has been redefined with the incorporation of evidence from multiple clinical trials. Recommendations from guidelines are updated regularly to reduce morbidity and mortality. However, heterogeneous care systems, physician perspectives, and patient behavior still lead to a disparity between evidence and clinical practice. The quality of care has been established and become an integral part of modern healthcare in order to increase the likelihood of desired health outcomes and adhere to professional knowledge. For patients with STEMI, measuring the quality of care is a multifactorial and multidimensional process that cannot be estimated solely based on patients’ clinical outcomes. The care of STEMI is similar to the concept of “the chain of survival” that emphasizes the importance of seamless integration of five links: early recognition and diagnosis, timely reperfusion, evidence-based medications, control of cholesterol, and cardiac rehabilitation. Serial quality indicators, reflecting the full spectrum of care, have become a widely used tool for assessing performance. Comprehension of every aspect of quality assessment and indicators might be too demanding for a physician. However, it is worthwhile to understand the concepts involved in quality improvement since every physician wants to provide better care for their patients. This article reviews a fundamental approach to quality care in STEMI.

show abstract

Recommendation to Use Wearable-Based mHealth in Closed-Loop Management of Acute Cardiovascular Disease Patients During the COVID-19 Pandemic

Abstract: Because of the rapid and serious nature of acute cardiovascular disease (CVD) especially ST segment elevation myocardial infarction (STEMI), a leading cause Manuscript

Cited by 29 publications

References 24 publications

Temperature Profile of Nasal Breathing for Respiration Monitoring in Ambulatory Settings

Temperature Profile of Nasal Breathing for Respiration Monitoring in Ambulatory Settings

Respinos: A Portable Device for Remote Vital Signs Monitoring of COVID-19 Patients

Quality care in ST-segment elevation myocardial infarction

Contact Info

Product

Resources

About